Quoin Pharmaceuticals, Ltd. (QNRX) insider trading.
In Q3 2026, insiders at Quoin Pharmaceuticals, Ltd. reported 6 non-derivative transactions on 6 Forms 3, 4 and 5: 4 open-market purchases worth $280K and 0 sales.
- Transactions
- 6
- Purchases (P)
- 4
- Sales (S)
- 0
- Net shares, P minus S
- 57,370
- Insiders
- 5
- Last filed
- 2026-09-01
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Culverwell Anthony James | Director | 2 | 1 | 0 |
| Lawlor Sally Bridget | Officer · Chief Financial Officer | 1 | 1 | 0 |
| Myers Michael | Director, Officer · Chief Executive Officer | 1 | 1 | 0 |
| Carter Denise P. | Director, Officer · Chief Operating Officer | 1 | 1 | 0 |
| Langer Dennis | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-31 | Culverwell Anthony James | P (A) | 6,146 | $4.88 | 40,364 | Form 4 |
| 2026-08-31 | Lawlor Sally Bridget | P (A) | 10,244 | $4.88 | 10,684 | Form 4 |
| 2026-08-31 | Myers Michael | P (A) | 20,490 | $4.88 | 37,713 | Form 4 |
| 2026-08-31 | Carter Denise P. | P (A) | 20,490 | $4.88 | 37,709 | Form 4 |
| 2026-08-27 | Culverwell Anthony James | A (A) | 31,352 | $5.15 | 34,218 | Form 4 |
| 2026-08-27 | Langer Dennis | A (A) | 34,534 | $5.15 | 56,243 | Form 4 |
Transaction codes in this quarter
Get QNRX insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1671502&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · QNRX company page · Quoin Pharmaceuticals, Ltd. on SEC.gov
Questions
Are insiders buying or selling Quoin Pharmaceuticals, Ltd. (QNRX)?
In Q3 2026, insiders at Quoin Pharmaceuticals, Ltd. reported 6 non-derivative transactions on 6 Forms 3, 4 and 5: 4 open-market purchases worth $280K and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Quoin Pharmaceuticals, Ltd. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/qnrx.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.